Abstract
Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.
Original language | English (US) |
---|---|
Pages (from-to) | S41 |
Journal | Anesthesiology |
Volume | 51 |
Issue number | 3 SUPPL |
State | Published - Jan 1 1979 |
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine